SuperTrans Medical

Antimicrobial resistance (AMR) is a growing health emergency, with the World Health Organisation (WHO) describing it as one of the biggest threats to global health. In direct response to this unmet medical need, SuperTrans Medical is developing novel antibiotics through the intelligent repurposing of existing FDA-approved drug molecules, resulting in superior properties